Loading...

Lansen Pharmaceutical Holdings Limited

0503.HK•HKSE
Healthcare
Drug Manufacturers - Specialty & Generic
HK$1.79
HK$0.52(40.94%)

Lansen Pharmaceutical Holdings Limited (0503.HK) Company Profile & Overview

Explore Lansen Pharmaceutical Holdings Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Lansen Pharmaceutical Holdings Limited (0503.HK) Company Profile & Overview

Lansen Pharmaceutical Holdings Limited, an investment holding company, develops, produces, and sells specialty pharmaceuticals for use in the field of rheumatology and dermatology in the People's Republic of China and internationally. The company operates through Pharmaceuticals, Cosmetics Products, and Healthcare Products segments. It offers Chinese medicine generic drugs; cosmetic products; and healthcare products. The company was founded in 2001 and is headquartered in Ningbo, the People's Republic of China. Lansen Pharmaceutical Holdings Limited is a subsidiary of Cathay International Pharma Manufacture and Distribution (China) Limited.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOLi Chen

Contact Information

https://www.lansen.com.cn
86 574 8804 6316
228 Xinfeng Road, Ningbo, 315174

Company Facts

652 Employees
IPO DateMay 7, 2010
CountryCN

Frequently Asked Questions

;